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A
lthough necrosis also plays a role, -cell death
by apoptosis precipitates type 1 diabetes and
also contributes to both type 2 diabetes and
islet graft failure after transplantation (1). It is
therefore surprising that apoptotic pathways, so well
explored in other cell types, have barely been character-
ized in -cells. A new study in Diabetes now adds to a
growing body of work that addresses how proinﬂamma-
tory cytokines stimulate the intrinsic apoptotic pathway in
-cells (2).
Apoptotic pathways converge on the activation of cys-
teine proteases of the caspase family (3). The distal point
of this cascade, caspase-3, in turn regulates the morpho-
logical and other features that characterize apoptosis.
Signaling upstream of caspase-3 involves two major arms
known as extrinsic and intrinsic pathways. The extrinsic
route is triggered by ligands of so-called death receptors,
which include Fas and tumor necrosis factor receptor
(TNFR). Activation of these receptors facilitates recruit-
ment and cleavage of initiator caspases (such as
caspase-8) that act directly on effector caspases such as
caspase-3.
In contrast, the intrinsic pathway (also called the mito-
chondrial or Bcl-2–regulated pathway) is triggered by a
loss of mitochondrial outer membrane potential, which
facilitates release of cytochrome c from the mitochondrial
membrane to seed a signaling complex that activates a
different set of initiator caspases, including caspase-9 (4).
This mitochondrial pathway can be initiated by multiple
stimuli and is subject to a complex hierarchical regulation
by members of the Bcl-2 family (5). Notably, the proapop-
totic members, Bax and Bak, directly promote the release
of cytochrome c. These are normally held in check by the
prosurvival subgroup, including Bcl-2, Bcl-xL, and Mcl-1.
Another tier of regulation is provided by the proapoptotic
BH3-only proteins, which sequester the prosurvival group
and thereby trigger Bax/Bak activation in a cell type– and
stimulus-speciﬁc manner (Fig. 1).
Cytokine signaling in -cells, especially the pathway
leading to nitric oxide (NO) generation, has been studied
for many years (6), and more recent studies have begun to
characterize the intrinisic pathway of apoptosis (7). How-
ever, the links between these two areas have remained
unclear, and the precise identity of the key players at each
level is poorly understood. Although many gaps remain,
the study by Grunnet et al. (2) provides evidence for one
route in linking proximal cytokine signaling to the intrinsic
pathway. The authors show that Bax activation underlies
cytochrome c release and caspase-9 cleavage and place
the BH3-only protein Bad as an upstream regulator. This
builds on previous ﬁndings that the BH3-only protein Bid
and the downstream multidomain effector molecules Bax
and Bak are required for cytokine-induced -cell death
(8) and that overexpression of the prosurvival molecule
Bcl-2 partially protects -cells from cytokine toxicity
(9). Bax and Bak are normally both required for apopto-
sis, so a role for Bak in the process is also likely (10).
Moreover, Bad is a weak binder of the prosurvival
proteins and is therefore only a poor inducer of apopto-
sis (11). However, BH3-only proteins cooperate to in-
duce apoptosis in other cell types, so it is possible that
Bad and Bid (and potentially other BH3-only proteins)
also interact in -cells in response to cytokines (Fig. 1).
The new ﬁndings are interesting because the phosphor-
ylation status of Bad integrates signals arising on the
survival side from the akt pathway and on the proapop-
totic side from activation of the stress kinase JNK as well
as the calcium-regulated protein phosphatase calcineurin.
Of these potential mechanisms, the authors highlight the
role of calcineurin-mediated dephosphorylation of Bad in
rat -cells, consistent with earlier studies using MIN6N8
insulinoma cells (12). In human islets no such dephosphor-
ylation was observed, although FK506, a calcineurin inhib-
itor, did diminish cytokine-stimulated caspase-3 activity
and apoptosis under these conditions (2). This suggests
that calcineurin might act on additional substrates in
human -cells.
However, the involvement of calcineurin is intriguing
because it implicates a rise in cytosolic free–calcium
([Ca
2]i) as a mediator of apoptosis in response to cytokines.
How might this come about? One explanation involves
activation of low-voltage–activated calcium channels (13).
However, there is another possibility whereby cytokines
might chronically raise [Ca
2]i by transcriptional downregu-
lation of SERCA2b, a transporter responsible for pumping
calcium from the cytosol into the endoplasmic reticulum
(ER) (14). This mechanism has been hitherto viewed as a
potential trigger of ER stress. However, it might be more
directly linked to the intrinsic apoptotic pathway, which
might explain why ER stress is present but not always
necessary for cytokine-stimulated apoptosis (15). In any
event, the study by Grunnert et al. now impels further
investigation into the role and source of the increased [Ca
2]i
caused by proinﬂammatory cytokines.
Other interesting questions are raised. c-Jun NH2-termi-
nal kinase (JNK) is a key player in -cell apoptosis in
models of type 1 diabetes (6,16), but activation of this
stress kinase was not reduced by inhibition of cal-
cineurin—in contrast to the situation in some other cell
types. How JNK interacts with the intrinsic apoptotic
pathway in -cells therefore remains a key unresolved
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impact of calcineurin on nuclear factor-B (NF-B). Al-
though the NF-B–regulated gene iNOS plays less of a role
in human versus rodent -cells (6), the contribution of this
transcription factor is likely to be complex and its inter-
action with calcineurin would be a productive topic for
future investigation.
Finally, there is independent evidence of a role for a
phosphorylation-dependent interplay of Bad with glucoki-
nase in the maintenance of glucose-stimulated insulin
secretion (17,18). Thus, in addition to its potential role in
cytokine-mediated death, this molecule might also contrib-
ute to secretory defects in the context of type 1 as well as
type 2 diabetes. In any event, Bad-deﬁcient mice, such as
those employed in the glucokinase studies, could prove
useful in designing future experiments to determine the
involvement of Bad in apoptosis versus its role in -cell
growth/survival. Elucidation of the roles of other Bcl-2
family proteins in this context also awaits the application
of appropriate mouse models. The study by Grunnet et al.
now helps reﬁne the best avenues for future investigation.
ACKNOWLEDGMENTS
No potential conﬂicts of interest relevant to this article
were reported.
REFERENCES
1. Cnop M, Welsh N, Jonas JC, Jorns A, Lenzen S, Eizirik DL. Mechanisms of
pancreatic -cell death in type 1 and type 2 diabetes: many differences, few
similarities. Diabetes 2005;54(Suppl.2):S97–S107
2. Grunnet LG, Aikin R, Tonnesen MF, Paraskevas S, Blaabjerg L, Størling J,
Rosenberg L, Billestrup N, Maysinger D, Mandrup-Poulsen T. Proinﬂam-
matory cytokines activate the intrinsic apoptotic pathway in -cells.
Diabetes 2009;58:1807–1815
3. Zimmermann KC, Bonzon C, Green DR. The machinery of programmed cell
death. Pharmacol Ther 2001;92:57–70
4. Riedl SJ, Salvesen GS. The apoptosome: signalling platform of cell death.
Nat Rev Mol Cell Biol 2007;8:405–413
FIG. 1. Pathways of extrinsic and intrinsic apoptosis, highlighting roles of Bcl-2 family members. The expression in -cells of the various Bcl-2
family proteins listed is currently unknown, and their potential contributions are largely uncharacterized. The study of Grunnet et al. highlights
a pathway leading from the IL-1 receptor (IL-1R) to the intrinsic apoptotic pathway mediated via dephosphorylation of the BH3-only protein Bad.
Sequestering members of the prosurvival group of Bcl-2 proteins relieves inhibition of Bax/Bak leading to downstream caspase activation.
Previous work has identiﬁed a role for cleavage of Bid downstream of the TNFR, thus deﬁning a cross-talk mechanism between the extrinsic and
instrinsic apoptotic pathways (8). How other known signals arising from IL-1R interact with Bcl-2 family members in -cells is poorly understood.
For simplicity, full signaling events downstream of IL-1R and TNFR are omitted, such as their cross-talk with each other, as well as the
contribution of other relevant receptors such as that for interferon-.
-CELL APOPTOSIS
1726 DIABETES, VOL. 58, AUGUST 20095. Youle RJ, Strasser A. The BCL-2 protein family: opposing activities that
mediate cell death. Nat Rev Mol Cell Biol 2008;9:47–59
6. Eizirik DL, Mandrup-Poulsen T. A choice of death: the signal-transduction
of immune-mediated beta-cell apoptosis. Diabetologia 2001;44:2115–2133
7. Thomas HE, McKenzie MD, Angstetra E, Campbell PD, Kay TW. Beta cell
apoptosis in diabetes. Apoptosis. 26 March 2009 [Epub ahead of print]
8. McKenzie MD, Carrington EM, Kaufmann T, Strasser A, Huang DC, Kay
TW, Allison J, Thomas HE. Proapoptotic BH3-only protein Bid is essential
for death receptor–induced apoptosis of pancreatic -cells. Diabetes
2008;57:1284–1292
9. Rabinovitch A, Suarez-Pinzon W, Strynadka K, Ju Q, Edelstein D, Brownlee
M, Korbutt GS, Rajotte RV. Transfection of human pancreatic islets with an
anti-apoptotic gene (bcl-2) protects -cells from cytokine-induced destruc-
tion. Diabetes 1999;48:1223–1229
10. Lindsten T, Ross AJ, King A, Zong WX, Rathmell JC, Shiels HA, Ulrich E,
Waymire KG, Mahar P, Frauwirth K, Chen Y, Wei M, Eng VM, Adelman DM,
Simon MC, Ma A, Golden JA, Evan G, Korsmeyer SJ, MacGregor GR,
Thompson CB. The combined functions of proapoptotic Bcl-2 family
members bak and bax are essential for normal development of multiple
tissues. Mol Cell 2000;6:1389–1399
11. Yang E, Zha J, Jockel J, Boise LH, Thompson CB, Korsmeyer SJ. Bad, a
heterodimeric partner for Bcl-XL and Bcl-2, displaces Bax and promotes
cell death. Cell 1995;80:285–291
12. Chang I, Cho N, Kim S, Kim JY, Kim E, Woo JE, Nam JH, Kim SJ, Lee MS.
Role of calcium in pancreatic islet cell death by IFN-gamma/TNF-alpha.
J Immunol 2004;172:7008–7014
13. Wang L, Bhattacharjee A, Zuo Z, Hu F, Honkanen RE, Berggren PO, Li M.
A low voltage-activated Ca2 current mediates cytokine-induced pancre-
atic beta-cell death. Endocrinology 1999;140:1200–1204
14. Cardozo AK, Ortis F, Storling J, Feng YM, Rasschaert J, Tonnesen M, Van
Eylen F, Mandrup-Poulsen T, Herchuelz A, Eizirik DL. Cytokines down-
regulate the sarcoendoplasmic reticulum pump Ca
2 ATPase 2b and
deplete endoplasmic reticulum Ca
2, leading to induction of endoplasmic
reticulum stress in pancreatic -cells. Diabetes 2005;54:452–461
15. Akerfeldt MC, Howes J, Chan JY, Stevens VA, Boubenna N, McGuire
HM, King C, Biden TJ, Laybutt DR. Cytokine-induced -cell death is
independent of endoplasmic reticulum stress signaling. Diabetes 2008;
57:3034–3044
16. Bonny C, Oberson A, Negri S, Sauser C, Schorderet DF. Cell-permeable
peptide inhibitors of JNK: novel blockers of -cell death. Diabetes
2001;50:77–82
17. Danial NN, Gramm CF, Scorrano L, Zhang CY, Krauss S, Ranger AM, Datta
SR, Greenberg ME, Licklider LJ, Lowell BB, Gygi SP, Korsmeyer SJ. BAD
and glucokinase reside in a mitochondrial complex that integrates glyco-
lysis and apoptosis. Nature 2003;424:952–956
18. Danial NN, Walensky LD, Zhang CY, Choi CS, Fisher JK, Molina AJ,
Datta SR, Pitter KL, Bird GH, Wikstrom JD, Deeney JT, Robertson K,
Morash J, Kulkarni A, Neschen S, Kim S, Greenberg ME, Corkey BE,
Shirihai OS, Shulman GI, Lowell BB, Korsmeyer SJ. Dual role of
proapoptotic BAD in insulin secretion and beta cell survival. Nat Med
2008;14:144–153
H.E. THOMAS AND T.J. BIDEN
DIABETES, VOL. 58, AUGUST 2009 1727